Clinical Trial Update: Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder [Phase 3]

View source ↗

Summary

This clinical trial update reports completion of a Phase 3 study evaluating selegiline for Borderline Personality Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Selegiline (selegiline)

Snippet

Sponsor: Mood and Anxiety Research, Inc | Conditions: Borderline Personality Disorder | Phase 3 | Status: COMPLETED